Preliminary data obtained from a small, hospitalized group by Rodríguez-Tomàs et al. [81], confirmed later by a larger study involving over 1300 subjects divided into study and control groups [82], have shown that serum PON1 AREase activity in COVID-19 patients drops to about half the value characteristic for healthy individuals. The gene discussed is PON1; the disease is COVID-19.